BIO-Y A/S: Financial statements 2013
CVR: 25507800
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BIO-Y A/S (CVR 25507800) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK 29,194 compared with DKK -224,660 the year before. Equity in the 2013 report amounted to DKK 1,804,534. The solvency ratio was 25.8%.
- Profit/Loss
- DKK 29,194
- Equity
- DKK 1,804,534
- Total Assets
- DKK 7,000,442
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | 29 t. | 1.8 mio. | - |
| 2012 | - | -24 t. | -225 t. | 1.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of July 22, 2013, Peter Minor has joined the board of directors of BIO-Y A/S.
As of July 22, 2013, Kai Frode Christensen has left the board of directors of BIO-Y A/S.
BIO-Y A/S has published its annual report for 2012. Gross profit came to DKK -24,168, and the net result was DKK -224,660.
About BIO-Y A/S
BIO-Y A/S is a Danish company of the type Aktieselskab based in Helsingør, founded in 2000. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GENOMICS A/S and SCSK 3327 A/S. The company is owned by Holdingselskabet af 26. oktober 2023 ApS and Hamlet Investments Limited. The company has 1 employee (2026). In 2024, the company reported a gross profit of DKK -43,680 and a net result of DKK -1,013,053 compared with DKK -782,767 the year before. Equity in the 2024 report amounted to DKK -3,717,025.